These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 11589627)
41. Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Angulo A; Suto C; Heyman RA; Ghazal P Mol Endocrinol; 1996 Jul; 10(7):781-93. PubMed ID: 8813719 [TBL] [Abstract][Full Text] [Related]
42. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism. Allegretto EA; McClurg MR; Lazarchik SB; Clemm DL; Kerner SA; Elgort MG; Boehm MF; White SK; Pike JW; Heyman RA J Biol Chem; 1993 Dec; 268(35):26625-33. PubMed ID: 8253793 [TBL] [Abstract][Full Text] [Related]
43. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis. Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523 [TBL] [Abstract][Full Text] [Related]
44. Metabolism to a response pathway selective retinoid ligand during axial pattern formation. Pijnappel WW; Folkers GE; de Jonge WJ; Verdegem PJ; de Laat SW; Lugtenburg J; Hendriks HF; van der Saag PT; Durston AJ Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15424-9. PubMed ID: 9860984 [TBL] [Abstract][Full Text] [Related]
46. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. Pan L; Eckhoff C; Brinckerhoff CE J Cell Biochem; 1995 Apr; 57(4):575-89. PubMed ID: 7615643 [TBL] [Abstract][Full Text] [Related]
47. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition. Pignatello MA; Kauffman FC; Levin AA Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355 [TBL] [Abstract][Full Text] [Related]
48. Receptor-selective retinoids implicate retinoic acid receptor alpha and gamma in the regulation of bmp-2 and bmp-4 in F9 embryonal carcinoma cells. Rogers MB Cell Growth Differ; 1996 Jan; 7(1):115-22. PubMed ID: 8788040 [TBL] [Abstract][Full Text] [Related]
49. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation. Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312 [TBL] [Abstract][Full Text] [Related]
50. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Zhao Z; Zhang ZP; Soprano DR; Soprano KJ Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808 [TBL] [Abstract][Full Text] [Related]
51. Activation of the orphan receptor RIP14 by retinoids. Zavacki AM; Lehmann JM; Seol W; Willson TM; Kliewer SA; Moore DD Proc Natl Acad Sci U S A; 1997 Jul; 94(15):7909-14. PubMed ID: 9223286 [TBL] [Abstract][Full Text] [Related]
52. Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity. Alam M; Zhestkov V; Sani BP; Venepally P; Levin AA; Kazmer S; Li E; Norris AW; Zhang XK; Lee MO J Med Chem; 1995 Jun; 38(13):2302-10. PubMed ID: 7608895 [TBL] [Abstract][Full Text] [Related]
53. RXR-dependent and RXR-independent transactivation by retinoic acid receptors. Schräder M; Wyss A; Sturzenbecker LJ; Grippo JF; LeMotte P; Carlberg C Nucleic Acids Res; 1993 Mar; 21(5):1231-7. PubMed ID: 8385314 [TBL] [Abstract][Full Text] [Related]
54. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line. Wan YJ; Cai Y; Magee TR Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077 [TBL] [Abstract][Full Text] [Related]
55. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Mangelsdorf DJ; Borgmeyer U; Heyman RA; Zhou JY; Ong ES; Oro AE; Kakizuka A; Evans RM Genes Dev; 1992 Mar; 6(3):329-44. PubMed ID: 1312497 [TBL] [Abstract][Full Text] [Related]
56. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma. Wan H; Hong WK; Lotan R Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249 [TBL] [Abstract][Full Text] [Related]
57. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222 [TBL] [Abstract][Full Text] [Related]
59. Different response to retinoic acid of two teratocarcinoma cell lines. Wan YJ; Wang L; Wu TC Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852 [TBL] [Abstract][Full Text] [Related]
60. Expression of retinoid X receptors and COUP-TFI in a human salivary gland adenocarcinoma cell line. Kyakumoto S; Nemoto T; Sato N; Ota M Biochem Cell Biol; 1997; 75(6):749-58. PubMed ID: 9599664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]